CIGNA PATHWELL
LIVE

Serial Number

97037992

Owner

CIGNA INTELLECTUAL PROPERTY, INC.

First Use Date

Jun 1, 2022

Filing Date

Sep 21, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CIGNA PATHWELL Trademark

Serial Number: 97037992 • Registration: 7706750

CIGNA PATHWELL is a trademark filed by CIGNA INTELLECTUAL PROPERTY, INC. on September 21, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

CIGNA INTELLECTUAL PROPERTY, INC. (562 trademarks)

300 Bellevue Parkway
Wilmington, DE 19809

Entity Type: 03

Trademark Details

Filing Date

September 21, 2021

Registration Date

February 25, 2025

First Use Anywhere

June 1, 2022

First Use in Commerce

June 1, 2022

Published for Opposition

February 7, 2023

Goods & Services

Pharmacy benefit management services; pharmacy benefit management consulting services; medical benefit management services concerning insurance; advisory services and consultancy regarding medical insurance healthcare benefits, in-network coverage and pharmacy benefits; provision of information and analysis in the fields of healthcare plan benefits and pharmacy benefits; prescription health care benefit coverage plans services, namely, providing insurance underwriting and claims administration of prescription drug plans for qualified beneficiaries; administration of pharmacy benefit plans concerning insurance; pharmacy benefit management services concerning insurance, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, and providing a predictive model to determine patients' future prescription drug and healthcare habits, all to identify clinical benefits; prescription drug and healthcare benefit plan services, namely, providing information to patients regarding in-network services in the fields of disease management programs and chronic conditions

Cost management for the healthcare benefit and prescription drug benefit plans of others in the field of pharmaceuticals; business services, namely, pharmaceutical cost management services and drug utilization review services for the prescription drug and medical formulary plans of others; consulting services regarding healthcare costs management and retail pharmacy services; Drug utilization review services and drug and medical formulary cost management services; pharmaceutical and medical cost management services and drug utilization review services; in-network provider advisory services and consultancy services, strategic business analysis and business advice in the field of medical insurance regarding pharmacy benefit management and medical benefit management; business data analysis regarding health care benefit plan pharmaceutical end-user behavior and health care benefit plan healthcare use behavior; market study and analysis of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level; providing business intelligence services in the field of pharmacy benefit management; administration of employee benefit plans concerning pharmacy benefit plans; cost management for pharmacy and heath care benefit services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, and providing a predictive model to determine patients' future prescription drug and healthcare habits to identify potential cost savings

Advisory services and consultancy regarding healthcare; healthcare services, namely, wellness and disease management programs for patients; health care services, namely, disease management programs and complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication compliance and providing healthcare and medical information regarding health and safety issues regarding chronic conditions; providing medical information and analysis in the fields of healthcare and pharmaceuticals; providing information in the field of healthcare to pharmacy benefit management services clients, consultants and brokers

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 25, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 25, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 5, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 5, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 18, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 14, 2024 AITU
USE AMENDMENT FILED
Oct 3, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 3, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 29, 2024 EXRA
SOU EXTENSION 2 GRANTED
Feb 28, 2024 EX2G
SOU EXTENSION 2 FILED
Feb 28, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 28, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 3, 2023 EXRA
SOU EXTENSION 1 GRANTED
Sep 29, 2023 EX1G
SOU EXTENSION 1 FILED
Sep 29, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 29, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 4, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 7, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 18, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 3, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 15, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 15, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 15, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 5, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 5, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jul 5, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 23, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 24, 2021 NWOS
NEW APPLICATION ENTERED
Sep 24, 2021 NWAP